Osmessn.com

Image Credit: Business Wire PCI Pharma Services, a contract development and manufacturing organization (CDMO), will be purchasing a full stake in Ajinomoto Althea, Inc., a sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc., for an undisclosed amount.1 The deal is anticipated to be completed by May, and gives PCI its first-ever North American […]

Image Credit: Adobe Stock Images/OMS.com The International Air Transport Association (IATA) is celebrating 10 years of its Center of Excellence for Independent Validators (CEIV) program, which evaluates a company’s the air cargo supply chain efforts when it comes to quality, safety, and compliance.1 CEIV was officially launched in 2014 alongside CEIV Pharma in order to assist with […]

PC: How can stakeholders ensure that sustainability takes precedence, even over other important business drivers? Ganguly: There are three key takeaways from the panel—and from observing how the sustainability movement has evolved. First, it’s important to share practical proof points. In the early stages, we saw a lot of pledges, but now it’s time to […]

Image Credit: Adobe Stock Images/Kotchakorn.com Among the older population, polypharmacy—the use of five or more medications—has skyrocketed. The issue lies in the fact that some meds lack any sort of indication, are used in way too high of a dose, or do more harm than good. These are considered “inappropriate.” As a result, there has […]

PC: You just wrapped up a panel discussion on “Uniting on Sustainability: How can we drive collaboration and ground-breaking initiatives to ensure ESG is a top business priority?” With sustainability being such a priority nowadays, what were some the highlights of the presentation? Ganguly: The panel was actually really refreshing because we moved away from […]

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and […]

Image Credit: Thermo Fisher Scientific Thermo Fisher Scientific has officially opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, CA.1 The plant is intended to speed up both the development and commercialization of cell therapies, in an effort to both grow the life sciences space and improve patient outcomes. As a result of the new […]

In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key sessions: “Establishing and Transitioning to a Foundation” and “Empowering Patients to Take Control of Their Healthcare.” The first session focuses on the important aspects of transitioning to a foundation, emphasizing the risks associated with regulations […]

Pharma companies expected to absorb any tariff hit in short term While US tariffs on pharmaceuticals may eventually raise drug prices, especially for generics, experts say brand-name costs will likely be absorbed by manufacturers in the short term—impacting profits, research, and staffing—while the broader goal may be to pressure companies into narrowing the price gap […]

Image Credit: Adobe Stock Images/Monchisa The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free biosimilar of Humira (adalimumab), across multiple inflammatory indications. The designation allows pharmacists, subject to state laws, to substitute Yuflyma for Humira without prescriber intervention, which could potentially improve access and lower costs for patients.1 “With […]

Bringing Biotech Innovation Across Borders A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets. The Role of Collaboration in Advancing Rare Disease Research In this video interview published by Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, […]

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and […]

For a child with autism spectrum disorder (ASD), effective care coordination across the required medical, physical rehabilitation, counseling, occupational, and speech providers is challenging, especially when the aim is to provide individualized care—at scale across many patients. Genial Care, a healthcare company focusing on personalized interventions for children with ASD, provides a successful example of […]

PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this event. These days, it’s a year-round project—365 days. Once this year’s event wraps, I’ll be thanking our speakers and delegates and immediately starting research conversations […]

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and […]

PC: When comparing this year to previous years, how would you say the main discussion points of LogiPharma have evolved? Robinson: I’m sure I’m not the only one saying this, but the big one is AI. The pace of growth in machine learning and automation has been incredible—even just compared to last year. We’re seeing […]